Filing Flows › Comparisons › XENE vs WHWK
Xenon Pharmaceuticals vs Whitehawk Therapeutics: XENE and WHWK compared
Xenon Pharmaceuticals is the larger company: $7.5M of revenue in its latest quarter (Q1 2025) against $7.1M for Whitehawk Therapeutics (Q1 2025). Whitehawk Therapeutics is more profitable, with an operating margin of -213.0% against -969.8%.
Where the money goes: XENE and WHWK
Xenon Pharmaceuticals (XENE) · Q1 2025
Xenon Pharmaceuticals, Q1 2025: revenue $7.5M, operating margin -969.8%, net loss $65.0M, operating cash flow −$61.7M. The chart follows the revenue to costs, profit and cash.
Whitehawk Therapeutics (WHWK) · Q1 2025
Whitehawk Therapeutics, Q1 2025: revenue $7.1M (+34% year over year), operating margin -213.0%, net earnings $73.0M, operating cash flow −$11.9M. The chart follows the revenue to costs, profit and cash.
| Xenon Pharmaceuticals (XENE) | Whitehawk Therapeutics (WHWK) | |
|---|---|---|
| Latest quarter | Q1 2025 | Q1 2025 |
| Revenue | $7.5M | $7.1M |
| Revenue growth, Y/Y | — | +34% |
| Operating margin | -969.8% | -213.0% |
| Net earnings | −$65.0M | $73.0M |
| Net margin | -867.3% | — |
| Operating cash flow | −$61.7M | −$11.9M |
| Market value | $3.6B | — |
| Analysts’ mean target | $71.75 | — |
Questions
Which is bigger, Xenon Pharmaceuticals or Whitehawk Therapeutics?
Xenon Pharmaceuticals is the larger company: $7.5M of revenue in its latest quarter (Q1 2025) against $7.1M for Whitehawk Therapeutics (Q1 2025).
Is Xenon Pharmaceuticals or Whitehawk Therapeutics growing faster?
Whitehawk Therapeutics is more profitable, with an operating margin of -213.0% against -969.8%.
More: Xenon Pharmaceuticals earnings · how Xenon Pharmaceuticals makes money · Whitehawk Therapeutics earnings · how Whitehawk Therapeutics makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed May 12, 2025; 10-Q filed May 8, 2025). Fiscal quarters can end on different dates. Not investment advice.